Franco Dammacco

Q: What Schools Are Affiliated With Franco Dammacco

Franco Dammacco is affiliated with the following schools: University of Milan, University of Salento, University of Bari, Stanford University, University of Padua, University of Ferrara

Franco Dammacco's AcademicInfluence.com Rankings

Franco Dammacco

Physics

#5365

World Rank

#7188

Historical Rank

physics Degrees

Download Badge

Physics

Franco Dammacco's Degrees

PhD Physics University of Milan
Masters Physics University of Milan
Bachelors Physics University of Milan

Why Is Franco Dammacco Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Franco Dammacco's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bone marrow angiogenesis and progression in multiple myeloma (1994) (676)
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. (1999) (649)
MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. (2013) (389)
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. (1999) (383)
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. (2003) (376)
Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines (2000) (340)
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. (2004) (320)
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. (2006) (291)
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. (1996) (288)
Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo (1999) (262)
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma (1999) (256)
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. (2005) (245)
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. (2005) (242)
Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. (2008) (236)
The cryoglobulins: an overview (2001) (235)
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. (1999) (222)
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. (1997) (220)
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. (2010) (219)
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. (1996) (216)
Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. (1994) (190)
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma (2001) (186)
Endothelial cells in the bone marrow of patients with multiple myeloma. (2003) (185)
Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study (2009) (181)
H. pylori infection and gastric cancer: state of the art (review). (2013) (176)
Antiangiogenesis is produced by nontoxic doses of vinblastine. (1999) (174)
Extra-articular manifestations of rheumatoid arthritis: An update. (2011) (173)
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. (1995) (169)
β2-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide1 (2003) (164)
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas (1999) (163)
Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. (2013) (162)
Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis. (2001) (162)
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. (2000) (161)
The role of the vascular phase in solid tumor growth: a historical review. (1999) (160)
Hepatitis C virus‐related proteins in kidney tissue from hepatitis C virus‐infected patients with cryoglobulinemic membranoproliferative glomerulonephritis (1997) (160)
Erdheim-Chester disease: a systematic review. (2015) (156)
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B‐cell non‐Hodgkin's lymphomas (2000) (155)
The role of mast cells in tumour angiogenesis (2001) (149)
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. (2012) (146)
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus–infected patients with mixed cryoglobulinemia (1995) (145)
Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. (1998) (144)
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. (2003) (142)
Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia (1992) (139)
Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA‐1, VLA‐4, LAM‐1, and CD44 (1995) (137)
Docetaxel versus paclitaxel for antiangiogenesis. (2002) (136)
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. (1991) (136)
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. (2005) (133)
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma (2008) (133)
Endothelial cell heterogeneity and organ specificity. (2002) (128)
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. (2002) (125)
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. (1990) (124)
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine (1999) (123)
Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. (2003) (122)
The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. (2000) (122)
Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. (1996) (119)
Targeted Therapies in Cancer (2010) (119)
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma (2001) (113)
Molecular Characterization of B Cell Clonal Expansions in the Liver of Chronically Hepatitis C Virus-Infected Patients1 (2001) (112)
Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. (1995) (108)
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis (1996) (107)
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non‐isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV‐infected patients (1996) (107)
Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells (2004) (106)
Overexpression of interleukin‐12 and T helper 1 predominance in lupus nephritis (2008) (106)
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67‐kilodalton laminin receptor (1993) (103)
Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. (2002) (101)
[Mesenchymal stem cells and bone regeneration]. (2008) (100)
Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. (1998) (100)
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib. (2008) (99)
Hepatitis C virus infection, cryoglobulinaemia, and beyond. (2006) (98)
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. (1997) (97)
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis (1998) (96)
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma (2009) (96)
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection (2004) (94)
Deregulated cytokine network and defective Th1 immune response in multiple myeloma (2001) (93)
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. (2002) (93)
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low‐grade lymphoma associated with autoimmune disease and in chronic gastritis (2000) (92)
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor. (2006) (92)
Non‐enveloped HCV core protein as constitutive antigen of cold‐precipitable immune complexes in type II mixed cryoglobulinaemia (2003) (91)
Autoreactivity in HIV-1 infection: the role of molecular mimicry. (1995) (91)
CD20‐depleting therapy in autoimmune diseases: from basic research to the clinic (2010) (89)
Bone marrow angiogenesis in patients with active multiple myeloma. (2001) (89)
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. (2006) (88)
αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells (2001) (85)
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies (2014) (85)
Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection (2005) (85)
Bortezomib as an antitumor agent. (2006) (85)
Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM‐induced antibody synthesis in vitro (1986) (84)
Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane (2001) (84)
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. (2015) (83)
Precancerous colorectal lesions (Review). (2013) (83)
Postnatal vasculogenesis (2001) (83)
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. (2006) (82)
CD20: a target antigen for immunotherapy of autoimmune diseases. (2005) (80)
Vascular endothelial growth factor and its receptors in multiple myeloma (2003) (79)
Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? (1998) (79)
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma (2007) (77)
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression (2004) (76)
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease (2003) (76)
Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes (2002) (75)
Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma (2011) (75)
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents. (2014) (73)
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing. (2015) (73)
Antibody Production and In Vitro Behavior of CD27-Defined B-Cell Subsets: Persistent Hepatitis C Virus Infection Changes the Rules (2006) (73)
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations (2006) (72)
Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture. (1998) (72)
Barrett's esophagus and esophageal cancer: an overview. (2012) (72)
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma. (2010) (71)
Autoantibodies to intracellular antigens: generation and pathogenetic role. (2011) (70)
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia (2003) (70)
Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage1 (2009) (69)
Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström's Macroglobulinemia (2008) (68)
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. (2010) (67)
New non-angiogenesis dependent pathways for tumour growth. (2003) (66)
Interleukin‐18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies (2006) (64)
Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine (2013) (63)
Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. (2008) (63)
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma (2004) (62)
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients (2016) (61)
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy. (2019) (60)
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma (2007) (59)
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. (2001) (59)
CXCR3-binding chemokines in multiple myeloma. (2004) (58)
Angiogenesis under normal and pathological conditions. (1991) (58)
Myeloma bone disease: pathogenetic mechanisms and clinical assessment. (2007) (57)
Goodpasture's disease: a report of ten cases and a review of the literature. (2013) (57)
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders (2015) (56)
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia (2006) (54)
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial. (2017) (53)
Prognostic value of serum IL‐10 and soluble IL‐2 receptor levels in aggressive non‐Hodgkin's lymphoma (1994) (53)
HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target (2013) (52)
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations. (2002) (52)
Mesenchymal stem cells: a new promise in anticancer therapy. (2011) (51)
Antiangiogenesis by cyclosporine. (1998) (51)
Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection (1993) (51)
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association (1993) (51)
Abdominal lymphoma and alpha chain disease. Report of three cases. (1972) (50)
Clinical implications of cytokine and soluble receptor measurements in patients with newly‐diagnosed aggressive non‐Hodgkin's lymphoma (1995) (49)
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy (1998) (49)
Managing myelodysplastic symptoms in elderly patients (2009) (49)
In vitro anti‐myeloma activity of TRAIL‐expressing adipose‐derived mesenchymal stem cells (2012) (48)
Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti‐DNA‐reactive IgG (1996) (48)
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients (2018) (48)
Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics. (2009) (47)
Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study. (1970) (47)
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience (2017) (47)
Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma (2008) (47)
Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus‐infected patients with and without mixed cryoglobulinaemia (2006) (45)
Detection of soluble interleukin‐2 receptor and interleukin‐10 in the serum of patients with aggressive non‐Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure (1994) (45)
Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. (2009) (45)
The immune escape in melanoma: role of the impaired dendritic cell function (2014) (45)
Functional osteoclast‐like transformation of cultured human myeloma cell lines (2005) (45)
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity. (1996) (45)
Angiogenesis and Progression in Human Melanoma (2010) (44)
Mixed cryoglobulinemia as a model of systemic vasculitis (1997) (43)
Immature dendritic cells in multiple myeloma are prone to osteoclast‐like differentiation through interleukin‐17A stimulation (2013) (43)
Angiogenesis induced by B-cell non-Hodgkin's lymphomas. Lack of correlation with tumor malignancy and immunologic phenotype. (1990) (42)
Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases. (1979) (42)
Antiangiogenesis for rheumatoid arthritis. (2005) (42)
New therapies in multiple myeloma (2007) (41)
Negative Regulation of the Osteoblast Function in Multiple Myeloma through the Repressor Gene E4BP4 Activated by Malignant Plasma Cells (2008) (39)
Cross-talk between hematopoiesis and angiogenesis signaling pathways. (2002) (39)
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection (2013) (38)
Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? (2011) (38)
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets (2012) (38)
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus (2003) (37)
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. (2001) (37)
Analbuminemia: Report of a Case and Review of the Literature 1 (1980) (37)
Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection (1996) (37)
Bone Marrow Angiogenesis and Plasma Cell Angiogenic and Invasive Potential in Patients with Active Multiple Myeloma (2002) (37)
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro. (2011) (36)
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. (2006) (36)
Proteolytic Activity of Human Lymphoid Tumor Cells. Correlation with Tumor Progression (2000) (36)
ANTIBODIES TO HEPATITIS C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER DISEASE (1989) (36)
Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas. (1996) (35)
Immune complex cryoglobulinaemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. (1971) (35)
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity (1997) (35)
Common Variable Immunodeficiency and Gastric Malignancies (2018) (35)
A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. (1991) (35)
Manumycin inhibits farnesyltransferase and induces apoptosis of drug‐resistant interleukin 6‐producing myeloma cells (2002) (34)
Oversecretion of Cytokines and Chemokines in Lupus Nephritis Is Regulated by Intraparenchymal Dendritic Cells (2009) (33)
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients (2013) (33)
Cancer Stem Cells in Multiple Myeloma (2011) (33)
THYROGLOBULIN ANTIBODIES IN LEPROSY. (1963) (31)
Therapeutic approaches to myeloma bone disease: an evolving story. (2012) (31)
Novel strategies in the treatment of castration-resistant prostate cancer (Review). (2012) (31)
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis (2018) (31)
Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both? (2009) (31)
Increased IL‐18 Production by Dendritic Cells in Active Inflammatory Myopathies (2007) (30)
The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review (2016) (30)
beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells. (2009) (30)
Hematopoiesis and angiogenesis: a link between two apparently independent processes. (2000) (30)
Role of the HLA Class II (2007) (29)
Two Structurally Different Rituximab-Specific CD20 Mimotope Peptides Reveal That Rituximab Recognizes Two Different CD20-Associated Epitopes1 (2009) (29)
A new case of mu heavy chain disease: clinical and immunochemical studies. (1974) (29)
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma. (2004) (29)
Waldenström's macroglobulinaemia with anti-IgG activity: a series of five cases. (1970) (28)
Pathogenic anti‐DNA idiotype‐reactive IgG in intravenous immunoglobulin preparations (1994) (28)
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme‐linked immunosorbent assay (2004) (28)
Identification of an Antigenic and Immunogenic Motif Expressed by Two 7-Mer Rituximab-Specific Cyclic Peptide Mimotopes: Implication for Peptide-Based Active Immunotherapy1 (2007) (28)
Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma (1995) (28)
Constitutive down-regulation of Osterix in osteoblasts from myeloma patients: in vitro effect of Bortezomib and Lenalidomide. (2010) (28)
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?1 (2018) (28)
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies (2014) (27)
Angiogenesis during tumor progression in human malignant melanoma. (1992) (27)
Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs (2010) (27)
Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies (2015) (26)
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus‐related antigens in hepatocellular carcinoma (1997) (26)
Double‐filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia (2008) (26)
Antibody Vh Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections (2011) (26)
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease (2019) (25)
Somatotropic function in short stature: Evaluation by integrated auxological and hormonal indices in 214 children (1993) (25)
Multifrequency rhythms of immunological functions. (1988) (25)
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial (2019) (24)
The occurrence of serum 7S IgM in diseases associated with immunoglobulin abnormalities. (1970) (24)
Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology. (1993) (24)
Expression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitro. (2008) (24)
Human recombinant interferon alpha-2a inhibits angiogenesis of chick area vasculosa in shell-less culture. (1996) (24)
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe. (2013) (24)
Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia. (1968) (23)
Cross-linking of Fas By Antibodies to a Peculiar Domain of gp120 V3 Loop Can Enhance T Cell Apoptosis in HIV-1–infected Patients (1996) (23)
Serum thyroglobulin and thyroid ultrasound studies in infants with congenital hypothyroidism. (1985) (23)
Recent Advances in Understanding the Pathogenesis of Anemia in Multiple Myeloma (2003) (22)
In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin. (2007) (22)
HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. (2006) (22)
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma. (2010) (21)
Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas (2008) (21)
Cancer treatment and the KIR–HLA system: an overview (2017) (21)
[Angiogenesis and tumor progression in melanoma]. (2000) (21)
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers (2018) (20)
Mast Cell Heterogeneity in B-cell Non-Hodgkin's Lymphomas: An Ultrastructural Study (2002) (20)
An unusual papain fragment containing the V H region of an IgG3 myeloma protein. (1972) (20)
Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy. (1982) (20)
Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy. (2004) (20)
Amyloidosis and Ocular Involvement: an Overview (2019) (20)
Role of active drug transporters in refractory multiple myeloma. (2009) (20)
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. (2007) (20)
Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome. (1989) (19)
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma (2012) (19)
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents. (2013) (18)
Angiogenesis, angiogenic factor expression and hematological malignancies. (2001) (18)
Biological functions and therapeutic use of erythropoiesis‐stimulating agents: perplexities and perspectives (2009) (18)
Hepatitis C virus infection and clonal B-cell expansion. (1996) (18)
CD20 Mimicry by a mAb Rituximab‐Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases (2005) (18)
Cyclosporin-A Efficacy in Chronic Idiopathic Urticaria (2011) (18)
Treatment of multiple myeloma: a randomized study of three different regimens. (1985) (18)
Mixed cryoglobulinemia: a model of virus-related disease in internal medicine. (2007) (17)
Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody. (1991) (17)
Antibody deficiency in paraproteinemia. (2009) (17)
Upregulation of Fas ligand secretion in non-lymphopenic stages of HIV-1 infection. (1998) (17)
Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery. (2014) (16)
Osteoclast-like Cell Formation by Circulating Myeloma B Lymphocytes: Role of RANK-L (2004) (16)
Lenalidomide in multiple myeloma: current experimental and clinical data (2012) (16)
Cryoglobulins and pyroglobulins: An overview (1986) (16)
Bone Marrow of Persistently Hepatitis C Virus-Infected Individuals Accumulates Memory CD8+ T Cells Specific for Current and Historical Viral Antigens: A Study in Patients with Benign Hematological Disorders1 (2007) (16)
Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection. (1995) (16)
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis (2000) (15)
Differential expression of two ICAM‐1 epitopes and LFA‐1 chains in B‐cell non‐Hodgkin's lymphomas (1994) (15)
Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. (1995) (15)
Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human alpha-2a interferon and partly mediated by fibroblast growth factor-2. (2002) (15)
Cell fusion and hyperactive osteoclastogenesis in multiple myeloma. (2011) (15)
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease (2005) (14)
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma (2016) (14)
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma (2012) (14)
Exogenous heparin induces fibronectin overexpression parallel to angiogenesis in the extracellular matrix of the chick embryo chorioallantoic membrane. (1997) (14)
Molecular alterations of IL‐6R, lck and c‐myc genes in transforming monoclonal gammopathies of undetermined significance (1996) (14)
Myeloma cells act as tolerogenic antigen‐presenting cells and induce regulatory T cells in vitro (2015) (14)
Dosing time and sex-related differences in the pharmacokinetics of cefodizime and in the circadian cortisol rhythm. (1988) (14)
Increased serum levels of β2m‐free HLA class I heavy chain in multiple myeloma (1999) (14)
Nesidioblastosis in Beckwith syndrome (1975) (13)
[Chemokines and tumors]. (2002) (13)
In vitro inhibition of anti-DNA producing cells from systemic lupus erythematosus patients by autologous anti-F(ab')2 antibodies. (1987) (13)
HCV‐associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation (2005) (13)
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3). (2010) (12)
In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane. (2002) (12)
Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center. (2011) (12)
Blockade of the Ras pathway by manumycin, a farnesyltransferase inhibitor, overcomes the resistance of myeloma plasma cells to Fas-induced apoptosis (2005) (12)
Rhythms in the ovulatory cycle. 3rd: Cortisol and dehydroepiandrosterone sulphate (DHEA-S). (1990) (12)
Rhythms in the ovulatory cycle. 2nd: LH, FSH, estradiol and progesterone. (1989) (12)
Original articleLocalization of hepatitis c virus antigens in liver and skin tissues of chronic hepatitis c virus—Infected patients with mixed cryoglobulinemia☆ (1995) (12)
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia (1998) (12)
Role of Hematopoietic Growth Factors in Angiogenesis (2002) (12)
VEINCTR-N, an Immunogenic Epitope of Fas (CD95/Apo-I), and Soluble Fas Enhance T-cell Apoptosis in vitro. II. Functional Analysis and Possible Implications in HIV-1 Disease (2000) (12)
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus (2018) (12)
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update (2018) (11)
Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic, and molecular studies (2002) (11)
Antimicrobial agents as biological response modifiers (BRM) and chrono-immunomodulation: an emerging relationship. (1988) (11)
Interleukin 28B Gene Polymorphisms in Hepatitis C Virus-related Cryoglobulinemic Vasculitis (2014) (11)
Deflazacort versus Prednisone in the Treatment of Essential Mixed Cryoglobulinemia A Between-Patient Controlled Clinical Study. (1992) (10)
Isotype, distribution and target analysis of lymphocyte reactive antibodies in patients with human immunodeficiency virus infection. (1989) (10)
Immunohistochemical detection of hepatitis C virus-related proteins in liver tissue. (1995) (10)
New clinical and immunological trends in cryoglobulinemia (1980) (10)
Primary intimal sarcoma of the thoracic aorta. (2005) (10)
Expression and distribution of a human colon-carcinoma-associated antigen in normal and diseased liver tissue. (1993) (10)
Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements (2020) (10)
Serum elevations of soluble Fas (CD95/Apo-I) concur in deregulating T cell apoptosis during active lupus disease (2002) (10)
Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements (2020) (10)
Cryoimmunoglobulinemia in four sisters. (1978) (10)
Thymic stromal lymphopoietin in hepatitis C virus-related cryoglobulinemic vasculitis: gene expression level and protein distribution (2015) (10)
Anemia in Multiple Myeloma: Role of Deregulated Plasma Cell Apoptosis (2002) (10)
A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis (2018) (9)
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis (2013) (9)
Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? (1995) (9)
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group. (2000) (9)
[Common variable immunodeficiency]. (1996) (9)
Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during β-interferon therapy of hepatitis C virus-associated chronic active liver disease (1992) (9)
Characterization studies of thyroglobulin antibodies in leprosy. An immunological study of diethylaminoethylcellulose chromatographic fractions. (1967) (9)
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype. (1999) (9)
Effects of cefodizime on non-specific immune functions in patients with multiple myeloma (2005) (9)
Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. (2001) (9)
Circatrigintan rectal temperature and endocrine rhythms of clinically healthy, menstrually cycling women. (1987) (9)
Functional expression of the calcitonin receptor by human T and B cells. (2009) (9)
In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma (2006) (9)
Human CD4-internal antigen anti-idiotypic monoclonal antibody: induction of a CD4-specific response in humans. (1996) (9)
Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti‐HCV‐positive intravenous immunoglobulins (1993) (8)
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. (1995) (8)
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma. (2002) (8)
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count. (2009) (8)
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation (2007) (8)
The expanding spectrum of clinical and laboratory features of IgE myeloma (1980) (8)
Molecular specificities of CD4+ T cell-reactive IgM in human immunodeficiency virus (HIV-1) infection. (1994) (8)
Macrophages in Skin Cancer: Quantitative and Functional Studies 1 (1979) (8)
Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia (2014) (8)
A case of IgAK-myelomatosis with two urinary Bence-Jones proteins (BJK and BJL) and multiple chromosomal abnormalities. (1969) (8)
Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances (2020) (8)
Low oral dose of clonidine: an effective test of growth hormone reserve. (1983) (8)
Human CD4 “internal antigen” mimicry by anti-idiotypic monoclonal antibodies (1994) (8)
Endothelial cells in the bone marrow of multiple myeloma (2003) (8)
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment. (2016) (7)
90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma (2011) (7)
Effects of 2-bromo-alpha-ergocryptine and pimozide on growth hormone secretion in man. (1976) (7)
HCV infection and cryoglobulinemia (2012) (7)
PEAK GH RESPONSE TO VARIOUS PROVOCATIVE STIMULI IN CHILDREN WITH NORMAL AND FAMILIAL SHORT STATURE (1993) (7)
Clinical and Experimental Medicine (2018) (7)
Neutropenia and G-CSF in lymphoproliferative diseases (2013) (7)
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements (2022) (7)
Absence of streptococcal protein G (PG)‐specific determinant in the Fab region of human IgG2 (1997) (7)
Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma. (1985) (6)
Hepatitis-C-virus-related chronic liver disease of sporadic type: clinical, serological and histological features. (1992) (6)
Rhythms in the ovulatory cycle. 1st: Prolactin. Chronobiological Research Group on Synthetic Peptides in Medicine. (1989) (6)
Long-term survival in multiple myeloma: a single-center experience (2008) (6)
Cryoglobulinemia in lepromatous leprosy: an immune complex phenomenon. (1971) (6)
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant. (1997) (6)
ESAs not the culprit: More studies required (2008) (6)
Kinetics of anti-hepatitis C virus response during acute hepatitis in an immunosuppressed HCV chronically infected patient. (1991) (6)
Systemic Vasculitides: Current Status and Perspectives (2016) (6)
Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia. (2008) (6)
Impaired chemiluminescence response by neutrophils in patients with multiple myeloma (1986) (6)
IgD-myelomatosis. Report of a case. (2009) (6)
Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia. (1988) (6)
Lung scanning and clearance of inhaled radiogold (198Au) particles in three patients with microlithiasis. (1981) (5)
A rapid direct microwave irradiation technique for demonstrating hepatitis C virus-associated C100 protein in formalin-fixed liver tissue (1992) (5)
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile (1998) (5)
Gene expression analysis of Manumycin, a natural farnesyltransferase (FTase) inhibitor, in drug-resistant IL-6-producing myeloma cells. (2005) (5)
Size variants of beta‐2‐microglobulin‐free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma (2003) (5)
Inhibitory effect of cyproheptadine administration on the sleep-related growth hormone secretion in man. (1977) (5)
Assessment of Safety and the Immune Response to the CD4 “Internal Antigen” Mouse Anti-Idiotypic MAb 16D7 in Four Patients with SLE (2004) (5)
Immunomodulation of T and B cell functions in multiple myeloma patients treated with combined erythropoietin and α-interferon therapy (1995) (5)
p16 gene analysis in multiple myeloma (MM). (1996) (5)
LFA-1 expression on CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNβ-1a (2001) (5)
Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection. (2001) (5)
Alsactide: ACTH-agonist for use in microdoses in brain-adrenal and other feedsidewards. (1987) (5)
Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases. (1997) (5)
Upregulation of erythroblast apoptosis by malignant plasma cells: a new pathogenetic mechanism of anemia in multiple myeloma. (2002) (5)
HCV RNA Genomic sequences and HCV‐E2 glycoprotein in sural nerve biopsies from HCV‐infected patients with peripheral neuropathy (2018) (4)
Rhythms in the ovulatory cycle. 1st: prolactin (1989) (4)
Monoclonal antibodies against human anti-F(ab')2 antibodies react with light chain epitopes. (1991) (4)
Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus. (1991) (4)
The Occurrence of Plasma Fibronectin in Mixed Cryoglobulins from Patients with Liver Cirrhosis1 (1984) (4)
Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review (2021) (4)
Distribution and antigenic analysis of circulating F(ab')2-reactive IgG in patients with HIV-1 infection. (1994) (4)
The bone marrow microenvironment in multiple myeloma: Cellular and molecular basis of disease progression (2011) (4)
Gamma heavy chain disease in a young girl. (1976) (4)
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody (1992) (4)
Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes). (1977) (4)
Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia. (2007) (4)
Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope. (2004) (4)
Immunogenicity of an Eight Amino Acid Domain Shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and Antigenic Analysis (2000) (4)
[Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects]. (2000) (4)
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit (1994) (4)
The Spectrum of Ocular Manifestations in Patients with Waldenström’s Macroglobulinemia (2021) (3)
Biosimilars and safety issues (2009) (3)
Pathogenic anti-DNAidiotype-reactiv e IgGinintravenous immunoglobulin preparations (1994) (3)
A case of IgAL-myelomatosis involving the intestinal tract. (1970) (3)
Pefloxacin in the antibacterial treatment of immunodepressed patients. (1990) (3)
Two-dimensional immunolectrophoresis as a diagnostic tool for heavy chain disease. (1975) (3)
Defibrotide in the treatment of Raynaud's phenomenon in patients with progressive systemic sclerosis or essential mixed cryoglobulinemia (1993) (3)
Analogues in immunology (1984) (3)
Angiogenesis and thalidomide in plasma cell disorders (2002) (3)
[Natural cytotoxicity: effector cells and role of the immunoglobulins (author's transl)]. (1981) (3)
Progress in chronophysiology of peptide hormones with emphasis on clinical application of analogues. (1985) (3)
Cancer Stem Cells in Multiple Myeloma and the Development of Novel Therapeutic Strategies (2019) (3)
VEGF and Tumor Progression in Human Melanoma (2004) (3)
Cell fusion in myeloma marrow microenvironment: role in tumor progression. (2013) (3)
[Idiopathic CD4+ lymphocytopenia: a case report]. (1995) (3)
Hypergammaglobulinemia, secondary macroglobulinemia and paraproteinemia in leprosy. (1969) (3)
AUTOIMMUNE REACTIONS AND MACROGLOBULINS IN LEPROSY (1967) (3)
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis (2001) (3)
Coordinate immunoreactivity to vascular endothelial growth factor receptor-2 and its ligand suggests a paracrine regulation during the development of the vascular system in the chick embryo bursa of Fabricius. (2001) (2)
The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules. (1992) (2)
New Clinical and Molecular Features of “Essential” Mixed Cryoglobulinemia (1994) (2)
Activation‐induced cytidine deaminase in B cells of hepatits C virus‐related cryoglobulinaemic vasculitis (2015) (2)
Lupoid features in a case of leprosy. (1967) (2)
Bone Metastases from Solid Tumors (2019) (2)
[Clinical and animal experiment studies of the resorption of dyes and colloidal radiogold in the large intestine]. (1969) (2)
[Common variable immunodeficiency. The authors' personal cases from the last 5 years]. (1996) (2)
Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay. (1984) (2)
Dasatinib Inhibits Multiple Myeloma Growth by Blocking PDGF-Rb and c-Src Activity in Patient-Derived Tumor and Endothelial Cells. (2007) (2)
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression. (2002) (2)
Paraproteinemia and neoplasia (1985) (2)
neoplastic or non-neoplastic lymphoproliferation lymph nodes of patients with type II mixed cryoglobulinemia and Detection and distribution of hepatitis C virus-related proteins in (2011) (2)
[Internal medicine and the holistic approach to the patient between globalization and advanced technologies]. (2012) (2)
A method for detecting specific anti-C100 protein antibodies of IgM isotype in hepatitis C virus infection (1992) (2)
Alpha‐2b recombinant interferon (Intron‐A) as maintenance treatment in multiple myeloma (1990) (2)
Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers. (1996) (2)
α-Fetoprotein and Australia Antigen in Primary Liver Cancer (1973) (2)
PIRR Therapy in HCV-Related Mixed Cryoglobulinemia (2012) (1)
Immune function in patients with multiple myeloma (1977) (1)
[Agammaglobulinemia and dysgammaglobulinemia: clinical and biological aspects]. (1967) (1)
Delayed complete remission in a patient with multiple myeloma (2008) (1)
Mechanisms of Cell Entry of Hepatitis C Virus (2012) (1)
Hepatitis C virus infection in essential mixed cryoglobulinemia (1991) (1)
Comprehensive Review Angiogenesis and Anti-Angiogenesis in Hematological Malignancies (2003) (1)
The eye is a common site of granulomatosis with polyangiitis. A collaborative study (2023) (1)
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects. (1991) (1)
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia. (2019) (1)
[Increase in somatotropin levels and the EEG during nocturnal sleep in the normal adult following administration of pimozide]. (1978) (1)
Stimulation of residual B-cell immunity in nude mice by pidotimod: an immunohistological study (1993) (1)
Human immunoglobulins in therapy. Rationale and clinical applications (1983) (1)
Genetic and epigenetic mechanisms of multiple myeloma (2004) (1)
MicroRNAs to know in Waldenstrom macroglobulinemia. (2009) (1)
Animal Models of ANCA-Associated Vasculitides (2016) (1)
Hepatitis-C Virus (Hcv)-Associated B-Cell Lymphoproliferative Disorders (1995) (1)
Monoclonal antibodies in the immunotherapy of autoimmune diseases. (2001) (1)
[The problem of the "non-secreting" myeloma]. (1973) (1)
Stimulation of antibody response in the gastrointestinal mucosa of immunodeficient mice by oral treatment with bacterial antigens. An immunoperoxidase study. (1989) (1)
Physicochemical and immunochemical abnormalities of residual IgG's in primary hypoimmunoglobulinemia. (1971) (1)
Highlights in clinical medicine—Giant cell arteritis, polymyalgia rheumatica and Takayasu’s arteritis: pathogenic links and therapeutic implications (2021) (1)
Low molecular weight IgM-immunoglobulins in Waldenström's macroglobulinemia. (1970) (1)
Defective IL-2 Activity in Chronic Active Liver Diseases. Correlation with T Cell Subsets and Serum HBsAg1 (1986) (1)
Fibronectin is a regular component of single-type and mixed cryoglobulins (1986) (1)
[Use of levodopa in the exploration of pituitary somatotropic activity]. (1976) (1)
Monoclonal gammopathy as a marker of primary cerebral lymphoma (2009) (1)
A placebo-controlled study of epoetin alfa in multiple myeloma (MM) patients with anaemia (1997) (1)
[Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia]. (1988) (1)
Incidence of the Australia antigen in various diseases. (1970) (0)
HCV-Induced Cryoglobulinemic Vasculitis: Pathogenesis and Therapeutic Implications (1996) (0)
Hepatitis and the Australia antigen. (1970) (0)
The Higher Prevalence of B-Cell Non-Hodgkin’s Lymphoma in HCV-Positive Patients with and Without Cryoglobulinemia (2012) (0)
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases (2017) (0)
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides (2008) (0)
Polyacrylamide electrophoresis. II. Study of serum proteins in multiple myeloma and Waldenstrom's macroglobulinemia. (1967) (0)
Comprar HCV Infection and Cryoglobulinemia | Dammacco, Franco | 9788847017047 | Springer (2011) (0)
O323: Vasculitis and its relationship to hepatitis C (2014) (0)
The Pivotal Role of C1qR in Mixed Cryoglobulinemia (2012) (0)
[CHARACTERIZATION OF THE SERUM ACTIVITY AND ANTIGAMMA GLOBULIN AND ANTI-GM FACTORS IN RHEUMATOID ARTHRITIS AND IN LIVER DISEASES]. (1964) (0)
[Diseases of immunologic insufficiency]. (1972) (0)
[Multiple myeloma and Hodgkin's lymphoma in the same patient]. (1985) (0)
Genes and proteins of myeloma endothelial cells to search specific targets of the tumor vasculature (2009) (0)
[Effects of thymopentin and recombinant interferon alpha 2A on the biochemiluminescence of neutrophil granulocytes in subjects with HIV infections]. (1987) (0)
[Behavior of plasma levels of metopirone after oral administration in children]. (1974) (0)
[Effects of meclastine on nocturnal sleep in normal subjects]. (1977) (0)
[Low molecular weight IgM in reactive mesenchymopathies. A new class of immunoglobulins?]. (1968) (0)
[Identification as 7S-19S of agglutinins caused by S. typhi in typhoid infections]. (1964) (0)
Evaluation of patient's acceptability of the new liquid formulation (norditropinsimplexx) in comparision with the freezedried in GHD children: open randomized; multicentre, two-period crossover trial (2002) (0)
OPTH_A_243203 775..793 (2020) (0)
Antibody HC-10-Specific Peptide Chain Epitope Mimicry by Monoclonal 2-Microglobulin-Free HLA Class I Heavy β (2013) (0)
[7S-19S CHROMATOGRAPHIC CHARACTERIZATION OF SOME ANTINUCLEAR FACTORS (ANTINUCLEAR FLUORESCENCE AND ANTINUCLEOPROTEIN FACTOR) IN SYSTEMIC LUPUS ERYTHEMATOSUS AND IN OTHER DISEASES]. (1963) (0)
[Human immunoglobulins in therapy. Rational bases and clinical applications]. (1983) (0)
chronic lymphocytic leukemia Prognostic value of enhanced bone marrow angiogenesis in early B-cell (2013) (0)
Contents Vol. 106, 2001 (2002) (0)
[Immunological deficiency syndromes, immunosuppression by drugs and occurrence of neoplasms: a casual association?]. (1985) (0)
Clinical and experimental medicine: innovation and continuity (2012) (0)
Infection of neoplastic B cells by HCV in low-grade non-Hodgkin's lymphomas associated with type II mixed cryoglobulinemia. (1999) (0)
[Tumor antigens in Hodgkin's lymphogranuloma]. (1976) (0)
Human Cancer Biology Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma (2009) (0)
[Effects of cyproheptadine on the sleep of normal man]. (1976) (0)
[Antigammaglobulin factors in myeloma and macroglobulinemia]. (1966) (0)
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure. (2023) (0)
Treatment of Hepatitis C Virus-Associated Chronic Liver Disease with ß-Interferon and Inosine Pranobex: Combination Schedule vs Monotherapies (1993) (0)
In reply. (2012) (0)
Gene Fusion in NSCLC (2019) (0)
Hepatitis C Virus-Infected Patients Expansions in the Liver of Chronically Molecular Characterization of B Cell Clonal Dammacco (2001) (0)
The clinical spectrum of the immunocompromised host: a pathology engineered by progress. (1993) (0)
[Uroproteins in various morbid conditions. Electrophoretic and chromatographic study]. (1967) (0)
Passage of human Bence Jones protein into the intestinal lumen; an isotopic and immunochemical study in the rat. (1968) (0)
Hepatitis-C virus infections and malignant lymphomas (1995) (0)
IDENTIFICATION OF AN ANTIGENIC AND IMMUNOGENIC MOTIF EXPRESSED BY TWO 7-MER RITUXIMAB-SPECIFIC CYCLIC PEPTIDES. (48.26) (2007) (0)
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. (2011) (0)
Chapter 2 Animal Models of ANCA-Associated Vasculitides (2019) (0)
[Amyloidosis. Immunochemical study]. (1975) (0)
Blood kinetics of 99mTc-pyrophosphate in anuric patients with renal osteodystrophy. (1978) (0)
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. (2010) (0)
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies and identifies a subset of anti-CENP antibody positive systemic sclerosis patients (2010) (0)
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab (1994) (0)
Selected Abstracts of the Research Forum of the Société Nationale Française de Gastroentérologie, November 18-19, 1972, Brussels, Belgium (1973) (0)
CLINICAL STUDIES AND ANIMAL EXPERIMENTS CONCERNING RESORPTION OF DIES AND COLLOIDAL RADIOACTIVE GOLD BY THE COLON. (1969) (0)
A rapid technique to demonstrate hepatitis C virus-associated C100 protein in formalin fixed liver tissue by direct microwave irradiation (1991) (0)
Ocular Manifestations in an Italian Cohort of Patients with Takayasu Arteritis. (2022) (0)
Resveratrol Exerts AntiproliferativeActivity and Induces Apoptosis inWaldenstro« m’s Macroglobulinemia (2008) (0)
Contents, Vol. 99, 1992 (1992) (0)
[The advent of biosimilars: new rules to guarantee patient safety]. (2009) (0)
State-of-the-Art Review Endothelial Cell Heterogeneity and Organ Specificity (2002) (0)
[Identification as 7S-19S of S.typhi agglutinins in typhoid infection sequelae and in other diseases]. (1964) (0)
[Complications of blood transfusion: a problem often underestimated]. (1984) (0)
A letter from the editor (1992) (0)
[7S-198 CHARACTERIZATION OF THE REAGINS OF THE WASSERMANN REACTION IN SYPHILITIC SERA AND SERA WITH FALSE POSITIVE BIOLOGY]. (1963) (0)
[Australia antigen in Mediterranean anemia]. (1970) (0)
Impaired erythropoiesis results in severe anemia in progressing multiple myeloma (MM) (2001) (0)
[CRYOGLOBULINEMIC PURPURA WITH RHEUMATOID FACTOR]. (1964) (0)
Circulating and bone marrow immunoglobulin-secreting cells in patients with monoclonal gammopathies. A simple and reliable marker for a B-cell function. (1985) (0)
[Immunologic aspects of bronchopulmonary carcinoma]. (1991) (0)
[On 2 cases of "alpha-2 myeloma"]. (1967) (0)
[Malabsorption syndrome and funicular myelosis in a patient with absence of gamma-A and gamma-M immunoglobulins in the blood]. (1966) (0)
Subject Index Vol. 106, 2001 (2002) (0)
[Effects of oral administration of L-dopa on the secretion of plasma growth hormone in subjects of pediatric age]. (1975) (0)
AN IMMUNOLOGICAL STUDY OF DIETHYLAMINOETHYLCELLULOSE CHROMATOGRAPHIC FRACTIONS (1967) (0)
[Immunity and tumors. Immunologic diagnosis of onco-fetal antigenic tumors]. (1973) (0)
Antiviral Therapy in HCV-Positive Non-Hodgkin’s Lymphoma: Pathogenetic Implications (2012) (0)
ROLE OF THE CHEMOKINE CXCL13 IN HEPATITIS C VIRUS-RELATED CRYOGLOBULINEMIC VASCULITIS (2008) (0)
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol. (1989) (0)
marrow endothelial cells of patients with multiple myeloma Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone (2011) (0)
[Disease of alpha chains: disproteinemic lymphomatosis]. (1970) (0)
Anti-Idiotypic Monoclonal Antibody (mAb) to Anti-CD4 mAb as Surrogate of Human CD4 Antigen (Ag) for Active Immunotherapy of Autoimmune Diseases (1997) (0)
Hypergamma-globulinemia, secondary macroglobulinemia and para-proteinemia in leprosy. (1969) (0)
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). (1999) (0)
237 The effectiveness and tolerability of recombinant human erythropoietin (Epoetin alfa) in patients with multiple myeloma refractory to chemotherapy (1995) (0)
[Immunologic deficiency syndromes]. (1974) (0)
Contents, Vol. 38, 1970 (1970) (0)
Lymph node angiogenesis in lymphoproliferative disorders: type II Mixed cryoglobulinemia as a model. (1995) (0)
[Alpha fetoprotein: a glycoprotein with immunoregulatory action?]. (1976) (0)
Anti-Glomerular Basement Membrane Disease (2016) (0)
aged 50 to 70: results of a randomized controlled trial Intermediate-dose melphalan improves survival of myeloma patients (2013) (0)
[PREVALENT 7S TYPE OF ANTISTREPTOLYSINE IN VARIOUS DISEASES]. (1963) (0)
Abstracts (1989) (0)
Differential isotype expression and binding properties of T cell-reactive antibodies in human immunodeficiency virus (HIV) infection (1992) (0)
Effectiveness of Iloprost in the Treatment of Cutaneous of and Pulmonary Fibrosis: A Randomised Multicentric Study in Patients with Systemic Sclerosis (SSc) (1996) (0)
[Evoked nystagmus in man: pharmacological analysis of some neurotransmitters]. (1978) (0)
ARGININE INFUSION FOLLOWED BY ARGININE PLUS GROWTH HORMONE(GH) RELEASING HORMONE ADMINISTRATION: A TEST TO ASSESS GH SECRETION (1993) (0)
HBeAg/Anti-HBe circulating immune complexes in patients chronically infected with hepatitis B virus (1989) (0)
[Plasma renin concentration in childhood nephropathies]. (1977) (0)
[The proteins of gastric juice. Immunoelectrophoretic study and level of immunoglobulins in some gastric diseases]. (1969) (0)
[Idiopathic CD4+ lymphocytopenia: a clinico-immunological syndrome of uncertain significance]. (1997) (0)
O.097 HCV infection, cryoglobulinemia and lymphomagenesis: An emerging picture (2006) (0)
Patients with Benign Hematological Disorders and Historical Viral Antigens: A Study in T Cells Specific for Current + Memory CD8 Virus-Infected Individuals Accumulates Bone Marrow of Persistently Hepatitis C (2007) (0)
POLYCYSTIC RENAL DISEASE, HYPERTENSION, AND IgA DEFICIENCY (1976) (0)
A method to detect specific anti-C100 protein anti-bodies of IgM isotype in hepatitis C virus infection (1991) (0)
A proficiency survey of plasma protein determination (1980) (0)
[Monoclonal antibodies in the diagnosis and therapy of lung cancer]. (1991) (0)
From the Double Helix to Oncogenomics and Precision Cancer Medicine (2019) (0)
Letter Nesidioblastosis in Beckwith syndrome. (1975) (0)
The case of primary systemic amyloidosis in chronic diarrhea, weight loss and hypotension. (1993) (0)
Alpha-fetoprotein and Australia antigen in primary liver cancer. (1973) (0)
99mTc-pyrophosphate kinetics in man (relationship between bone uptake and mineral content). (1978) (0)
[Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs]. (1993) (0)
Role of B-Cell-Attracting Chemokine-1 in HCV-Related Cryoglobulinemic Vasculitis (2012) (0)
[Measurement of the spontaneous growth hormone increase in short children. Diagnostic significance and neuroendocrine implications]. (1993) (0)
Edward C. Franklin a lifetime dedication to science (1984) (0)
ASSESSMENT OF GROWTH HORMONE PITUITARY RESERVE AND MAGNETIC RESONANCE IMAGING FINDINGS IN SHORT CHILDREN (1993) (0)
B2-M-FREE HEAVY CHAIN LEVELS OF HLA-CLASS I ANTIGEN COMBINED WITH SERUM IGM OR PLATELET COUNT PROVIDE TWO RELIABLE STAGING SYSTEMS IN MULTIPLE MYELOMA (2008) (0)
THE INHIBITORY EFFECT OF BETA 2ADRENORECEPTOR ACTIVATION BY SALBUTAMOL ON GH SECRETION IS AGE-DEPENDENT (1995) (0)
Reply: (2006) (0)
[Cryoglobulinemia in reactive mesenchymopathies]. (1967) (0)
Letter: Polycystic renal disease, hypertension, and IgA deficiency. (1976) (0)
Argyrophil cells hyperplasia (apudosis) in Beckwith syndrome. (1979) (0)
Flogosis and heart involvement in large vessel vasculitis (2017) (0)
[Behçet's disease and angioedema induced by ACE-inhibitors: 2 unusual pathological pictures]. (1997) (0)
[Effect of oral administration of metopirone on somatotropic hormone and on carbohydrate metabolism in children]. (1974) (0)
[Anti-idiotypic antibodies in therapy: current status and prospects]. (1989) (0)
[Immunoenzyme technics in immunohistochemistry. Immunoperoxidase and alkaline immunophosphatase]. (1988) (0)
A letter from the editor (1992) (0)
A chronobiological approach to the effects of cefodizime on monocytic and granulocytic functions of patients with multiple myeloma. (1991) (0)
Soluble CD4 and commercial immunoglobulin (1994) (0)
multiple myeloma malignant plasma cells: a major pathogenetic mechanism of anemia in Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly (2013) (0)
KETOCONAZOLE TREATMENT OF TWO ADOLESCENTS WITH CUSHING'S DISEASE (1993) (0)
Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström Macroglobulinemia (2019) (0)
HCV-Related Cryoglobulinemic Vasculitis: An Overview (2016) (0)
Concluding remarks (1986) (0)
Human anti-mouse antibodies interfere in the determination of sCD4 in intravenous immunoglobulin preparations (1995) (0)
[Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies]. (1977) (0)
Demonstration of immune complexes by mixed immunofluorescence in synovial membrane of patients with rheumatoid arthritis. (1970) (0)
Plasmapheresis 82: Concluding remarks and perspectives for the future (1983) (0)
[Plasma concentrations of metopirone after oral administration in the child]. (1976) (0)
[Comparison of 2 different methods for demonstration of anti-nuclear factors]. (1963) (0)
Maintenance Treatment with Recombinant Interferon Alfa-2b Prolongs Remission and Survival in Patients with Multiple Myeloma Responding to Induction Chemotherapy (1992) (0)
[Postgraduate teaching of internal medicine in the United States]. (2003) (0)
[Hepatitis and the Australia antigen]. (1970) (0)
Immunodeficienza comune variabile (1996) (0)
Two-dimensional immunoelectrophoresis: a new simplified method. (1975) (0)
[Immunochemical characteristics of residual IgG's in primary hypogammaglobulinemia]. (1971) (0)
antibody- dependent cellular cytotoxicity (see comments) virus-1 patients with evidence of T-cell apoptosis and mediate Antiphosphatidylserine antibodies in human immunodeficiency (2011) (0)
Soluble CD4antigen reactivity inintravenous immunoglobulin preparations: isitspecific? (1995) (0)
[Immunologic deficiency syndromes]. (1974) (0)
[Methergoline and nocturnal sleep in normal subjects]. (1977) (0)
Abdominal Lymphoma and α-Chain Disease: Report of Three Cases* (1971) (0)
Vasculitis in Connective Tissue Diseases (2016) (0)
[Characterization of the antinuclear factors revealed by immunofluorescence]. (1965) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Franco Dammacco?

Franco Dammacco is affiliated with the following schools: